Studijní program
Předměty
Publikace
- Organic Cation Transporter 3 (OCT3/SLC22A3) and Multidrug and Toxin Extrusion 1 (MATE1/SLC47A1) Transporter in the Placenta and Fetal Tissues: Expression Profile and Fetus Protective Role at Different Stages of Gestation2013 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics2013 | Farmaceutická fakulta v Hradci Králové
- Synchronized Activity of Organic Cation Transporter 3 (Oct3/Slc22a3) and Multidrug and Toxin Extrusion 1 (Mate1/Slc47a1) Transporter in Transplacental Passage of MPP+ in Rat2012 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy2022 | Farmaceutická fakulta v Hradci Králové
- ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia2022 | Farmaceutická fakulta v Hradci Králové
- Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors2020 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- In vitro function and in situ localization of Multidrug Resistance-associated Protein (MRP)1 (ABCC1) suggest a protective role against methyl mercury-induced oxidative stress in the human placenta2020 | Farmaceutická fakulta v Hradci Králové
- Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta2020 | Farmaceutická fakulta v Hradci Králové
- Cyclin-dependent kinase inhibitors AZD5438 and R547 show potential for enhancing efficacy of daunorubicin-based anticancer therapy: Interaction with carbonyl-reducing enzymes and ABC transporters2019 | Farmaceutická fakulta v Hradci Králové
- The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta2019 | Farmaceutická fakulta v Hradci Králové
Loading network view...